Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Proc Natl Acad Sci U S A ; 112(4): 1107-12, 2015 Jan 27.
Artículo en Inglés | MEDLINE | ID: mdl-25583476

RESUMEN

Gastric cancer (GC) is a highly heterogeneous disease. To identify potential clinically actionable therapeutic targets that may inform individualized treatment strategies, we performed whole-exome sequencing on 78 GCs of differing histologies and anatomic locations, as well as whole-genome sequencing on two GC cases, each with three primary tumors and two matching lymph node metastases. The data showed two distinct GC subtypes with either high-clonality (HiC) or low-clonality (LoC). The HiC subtype of intratumoral heterogeneity was associated with older age, TP53 (tumor protein P53) mutation, enriched C > G transition, and significantly shorter survival, whereas the LoC subtype was associated with younger age, ARID1A (AT rich interactive domain 1A) mutation, and significantly longer survival. Phylogenetic tree analysis of whole-genome sequencing data from multiple samples of two patients supported the clonal evolution of GC metastasis and revealed the accumulation of genetic defects that necessitate combination therapeutics. The most recurrently mutated genes, which were validated in a separate cohort of 216 cases by targeted sequencing, were members of the homologous recombination DNA repair, Wnt, and PI3K-ERBB pathways. Notably, the drugable NRG1 (neuregulin-1) and ERBB4 (V-Erb-B2 avian erythroblastic leukemia viral oncogene homolog 4) ligand-receptor pair were mutated in 10% of GC cases. Mutations of the BRCA2 (breast cancer 2, early onset) gene, found in 8% of our cohort and validated in The Cancer Genome Atlas GC cohort, were associated with significantly longer survivals. These data define distinct clinicogenetic forms of GC in the Chinese population that are characterized by specific mutation sets that can be investigated for efficacy of single and combination therapies.


Asunto(s)
Adenocarcinoma/genética , Adenocarcinoma/mortalidad , Pueblo Asiatico , Mutación , Proteínas de Neoplasias/genética , Neoplasias Gástricas/genética , Neoplasias Gástricas/mortalidad , Adenocarcinoma/terapia , Factores de Edad , Estudios de Casos y Controles , China/epidemiología , Análisis Mutacional de ADN , Bases de Datos de Ácidos Nucleicos , Supervivencia sin Enfermedad , Femenino , Estudio de Asociación del Genoma Completo , Recombinación Homóloga , Humanos , Masculino , Neoplasias Gástricas/terapia , Tasa de Supervivencia
2.
Mech Ageing Dev ; 129(6): 304-12, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18400259

RESUMEN

Aging is associated with progressive decline in energetic reserves compromising cardiac performance and tolerance to injury. Although deviations in mitochondrial functions have been documented in senescent heart, the molecular bases for the decline in energy metabolism are only partially understood. Here, high-throughput transcription profiles of genes coding for mitochondrial proteins in ventricles from adult (6-months) and aged (24-months) rats were compared using microarrays. Out of 614 genes encoding for mitochondrial proteins, 94 were differentially expressed with 95% downregulated in the aged. The majority of changes affected genes coding for proteins involved in oxidative phosphorylation (39), substrate metabolism (14) and tricarboxylic acid cycle (6). Compared to adult, gene expression changes in aged hearts translated into a reduced mitochondrial functional capacity, with decreased NADH-dehydrogenase and F(0)F(1) ATPase complex activities and capacity for oxygen-utilization and ATP synthesis. Expression of genes coding for transcription co-activator factors involved in the regulation of mitochondrial metabolism and biogenesis were downregulated in aged ventricles without reduction in mitochondrial density. Thus, aging induces a selective decline in activities of oxidative phosphorylation complexes I and V within a broader transcriptional downregulation of mitochondrial genes, providing a substrate for reduced energetic efficiency associated with senescence.


Asunto(s)
Envejecimiento , Perfilación de la Expresión Génica , Mitocondrias/metabolismo , Miocardio/metabolismo , Transcripción Genética , Adenosina Trifosfato/metabolismo , Animales , Senescencia Celular , Modelos Biológicos , Análisis de Secuencia por Matrices de Oligonucleótidos , Fosforilación Oxidativa , ATPasas de Translocación de Protón/metabolismo , Ratas , Ratas Endogámicas F344 , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
3.
Antioxid Redox Signal ; 9(6): 661-9, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17511582

RESUMEN

Obstructive sleep apnea (OSA), the commonest form of sleep-disordered breathing, is characterized by recurrent episodes of intermittent hypoxia and sleep fragmentation. This study evaluated microarray measures of gene transcript levels in OSA subjects compared to age and BMI matched healthy controls. Measurements were obtained before and after: (a) a night of normal sleep in controls; and (b) a night of untreated apnea in OSA patients. All subjects underwent full polysomnography. mRNA from the whole blood samples was analyzed by HG-U133A and B Affymetrix GeneChip arrays using Spotfire 7.2 data analysis platform. After sleep in OSA patients, changes were noted in several genes involved in modulation of reactive oxygen species (ROS), including heme oxygenase 1, superoxide dismutase 1 and 2, and catalase. Changes were also observed in genes involved in cell growth, proliferation, and the cell cycle such as cell division cycle 25B, signaling lymphocyte activating molecule (SLAM), calgizzarin S100A11, B-cell translocation gene, Src-like adapter protein (SLAP), and eukaryotic translation initiation factor 4E binding protein 2. These overnight changes in OSA patients are suggestive of activation of several mechanisms to modulate, and adapt to, increased ROS developing in response to the frequent episodes of intermittent hypoxia.


Asunto(s)
Ciclo Celular/genética , Genoma Humano/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Estrés Oxidativo/genética , Apnea Obstructiva del Sueño/genética , Apnea Obstructiva del Sueño/patología , Adulto , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Salud , Humanos , Masculino , Especies Reactivas de Oxígeno
4.
Shock ; 25(5): 472-84, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16680012

RESUMEN

Lipopolysaccharide (LPS) is a major structural component of all Gram-negative organisms and has been implicated in Gram-negative sepsis and septic shock. In the present study, Affymetrix microarray analysis of RNA derived from murine macrophages treated with LPS in the absence or presence of the proteasome inhibitor lactacystin revealed that the vast majority of genes regulated by LPS is under control of the proteasome. Analysis of the data has revealed that the products of these genes participate in 14 distinct signaling pathways. This represents a novel approach to the identification of signaling pathways that are both toll-like receptor 4- and proteasome-dependent and may lead to the development of new drug targets in Gram-negative sepsis and septic shock.


Asunto(s)
Regulación Enzimológica de la Expresión Génica , Inflamación , Complejo de la Endopetidasa Proteasomal/fisiología , Transducción de Señal , Acetilcisteína/análogos & derivados , Acetilcisteína/metabolismo , Acetilcisteína/farmacología , Animales , Supervivencia Celular , Quimotripsina/farmacología , Lipopolisacáridos/metabolismo , Macrófagos/metabolismo , Ratones , Análisis de Secuencia por Matrices de Oligonucleótidos , Complejo de la Endopetidasa Proteasomal/metabolismo , Choque Séptico/metabolismo , Receptor Toll-Like 4/metabolismo
5.
Shock ; 34(4): 390-401, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20160661

RESUMEN

Our previous work has provided strong evidence that the proteasome is central to most of the genes induced in mouse macrophages in response to LPS stimulation. In the studies presented here, we evaluated the role of the macrophage proteasome in response to a second microbial product CpG DNA (unmethylated bacterial DNA). For these studies, we applied Affymetrix microarray analysis of RNA derived from murine macrophages stimulated with CpG DNA in the presence or absence of proteasome inhibitor, lactacystin. The results of these studies revealed that similar to LPS, most of those macrophage genes regulated by CpG DNA are also under the control of the proteasome at 4 h. In contrast to LPS stimulation, however, many of these genes were induced much later than 4 h, at 18 h, in response to CpG DNA. Lactacystin treatment of macrophages completely blocked the CpG DNA-induced gene expression of TNF-α and other genes involved in the production of inflammatory mediators. These data strongly support the conclusion that similar to LPS, the macrophage proteasome is a key regulator of CpG DNA-induced signaling pathways.


Asunto(s)
ADN Bacteriano/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Complejo de la Endopetidasa Proteasomal/metabolismo , Transducción de Señal/efectos de los fármacos , Animales , Células Cultivadas , Femenino , Ratones , Análisis de Secuencia por Matrices de Oligonucleótidos , Transducción de Señal/genética
6.
J Vasc Interv Radiol ; 19(1): 111-9, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18192475

RESUMEN

PURPOSE: To use proteomic analysis to identify upregulated and downregulated proteins in thrombosed hemodialysis graft specimens. One of these significantly upregulated proteins was a disintegrin and metalloproteinase thrombospondin-1 (ADAMTS-1), and its expression and activity were determined in thrombosed hemodialysis grafts. MATERIALS AND METHODS: Hemodialysis vascular access samples (thrombosed veins, n = 8; control veins, n = 6) were obtained from patients who required surgical revision. Proteomic analysis was performed with isotope-coded affinity tag labeling with multidimensional liquid chromatography followed by tandem mass spectrometry on four thrombosed hemodialysis graft specimens with control veins. Expression of ADAMTS-1 was confirmed by performing immunoprecipitation followed by Western blot analysis. Finally, immunohistochemistry was used to localize expression in a separate group of patients with thrombosed grafts. RESULTS: Thirty-nine unique proteins were common to all four patients. ADAMTS-1 was one of the only significantly upregulated protein (>38 fold). ADAMTS-1 expression was confirmed by performing immunoprecipitation and Western blot analysis and was significantly increased. ADAMTS-1 expression was localized to adventitial macrophages and neutrophils of thrombosed grafts. CONCLUSIONS: ADAMTS-1 was significantly upregulated in thrombosed hemodialysis grafts by mass spectrometric analysis and Western blot analysis. Expression was localized to adventitial macrophages and leukocytes. It is hypothesized that ADAMTS-1 may be related to intimal hyperplasia in hemodialysis vascular access grafts. Future work is planned on inhibiting ADAMTS-1 expression and determining the effect on intimal hyperplasia in hemodialysis grafts.


Asunto(s)
Proteínas ADAM/análisis , Implantación de Prótesis Vascular/efectos adversos , Oclusión de Injerto Vascular/enzimología , Diálisis Renal , Trombosis/enzimología , Proteína ADAMTS1 , Anciano , Prótesis Vascular , Implantación de Prótesis Vascular/instrumentación , Western Blotting , Estudios de Casos y Controles , Cromatografía Liquida , Femenino , Oclusión de Injerto Vascular/etiología , Oclusión de Injerto Vascular/patología , Humanos , Inmunohistoquímica , Inmunoprecipitación , Marcaje Isotópico , Macrófagos/enzimología , Masculino , Persona de Mediana Edad , Neutrófilos/enzimología , Politetrafluoroetileno , Diseño de Prótesis , Proteómica/métodos , Espectrometría de Masas en Tándem , Trombosis/etiología , Trombosis/patología , Resultado del Tratamiento , Regulación hacia Arriba
7.
Diabetes ; 57(11): 2933-42, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18716044

RESUMEN

OBJECTIVE: We determined whether reduced insulin sensitivity, mitochondrial dysfunction, and other age-related dysfunctions are inevitable consequences of aging or secondary to physical inactivity. RESEARCH DESIGN AND METHODS: Insulin sensitivity was measured by hyperinsulinemic-euglycemic clamp and ATP production in mitochondria isolated from vastus lateralis biopsies of 42 healthy sedentary and endurance-trained young (18-30 years old) and older (59-76 years old) subjects. Expression of proteins involved in fuel metabolism was measured by mass spectrometry. Citrate synthase activity, mitochondrial DNA (mtDNA) abundance, and expression of nuclear-encoded transcription factors for mitochondrial biogenesis were measured. SIRT3, a mitochondrial sirtuin linked to lifespan-enhancing effects of caloric restriction, was measured by immunoblot. RESULTS: Insulin-induced glucose disposal and suppression of endogenous glucose production were higher in the trained young and older subjects, but no age effect was noted. Age-related decline in mitochondrial oxidative capacity was absent in endurance-trained individuals. Although endurance-trained individuals exhibited higher expression of mitochondrial proteins, mtDNA, and mitochondrial transcription factors, there were persisting effects of age. SIRT3 expression was lower with age in sedentary but equally elevated regardless of age in endurance-trained individuals. CONCLUSIONS: The results demonstrate that reduced insulin sensitivity is likely related to changes in adiposity and to physical inactivity rather than being an inevitable consequence of aging. The results also show that regular endurance exercise partly normalizes age-related mitochondrial dysfunction, although there are persisting effects of age on mtDNA abundance and expression of nuclear transcription factors and mitochondrial protein. Furthermore, exercise may promote longevity through pathways common to effects of caloric restriction.


Asunto(s)
Envejecimiento , Ejercicio Físico/fisiología , Resistencia a la Insulina , Resistencia Física/fisiología , Adolescente , Adulto , Anciano , Western Blotting , ADN Mitocondrial/metabolismo , Femenino , Técnica de Clampeo de la Glucosa , Humanos , Hiperinsulinismo/sangre , Masculino , Persona de Mediana Edad , Mitocondrias Musculares/metabolismo , Proteínas Mitocondriales/metabolismo , Proteómica , Sirtuina 3 , Sirtuinas/metabolismo , Adulto Joven
8.
Proteomics ; 7(4): 588-596, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17309104

RESUMEN

Isotope-coded affinity tags (cICAT) coupled with mass spectrometric analysis is one of the leading technologies for quantitative proteomic profiling and protein quantification. We performed proteomic analysis of bovine aortic endothelial cells (BAEC) in response to laminar shear stress using cICAT labeling coupled with LC-MS/MS. Protein expressions in BAEC under 15 dynes/cm2 of shear stress for 10 min, 3 h, and 6 h were compared with matched stationary controls. Analysis of each sample produced 1800-2400 proteins at >or=75% confidence level. We found 142, 213, and 186 candidate proteins that were up- or down-regulated by at least two-fold after 10 min, 3 h, and 6 h of shear stress, respectively. Some of these proteins have known cellular functions and they encompass many signaling pathways. The signaling pathways that respond to shear stress include those of integrins, G-protein-coupled receptors, glutamate receptors, PI3K/AKT, apoptosis, Notch and cAMP-mediated signaling pathways. The validity of the mass spectrometric analysis was also confirmed by Western blot and confocal immunofluorescence microscopy. The present quantitative proteomic analysis suggests novel potential regulatory mechanisms in vascular endothelial cells in response to shear stress. These results provide preliminary footprints for further studies on the signaling mechanisms induced by shear stress.


Asunto(s)
Células Endoteliales/fisiología , Proteoma/análisis , Animales , Bovinos , Células Cultivadas , Cromatografía Liquida , Proteínas HSP70 de Choque Térmico/metabolismo , Marcaje Isotópico , Transducción de Señal/fisiología , Estrés Mecánico , Espectrometría de Masas en Tándem
9.
Am J Respir Cell Mol Biol ; 35(2): 236-42, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16543605

RESUMEN

Mycobacterium avium complex (MAC) causes chronic lung disease in immunocompetent people and disseminated infection in patients with AIDS. MAC is intrinsically resistant to many conventional antimycobacterial agents, it develops drug resistance rapidly to macrolide antibiotics, and patients with MAC infection experience frequent relapses or the inability to completely eradicate the infection with current treatment. Treatment regimens are prolonged and complicated by drug toxicity or intolerances. We sought to identify biochemical pathways in MAC that can serve as targets for novel antimycobacterial treatment. The cytochrome P450 enzyme, CYP51, catalyzes an essential early step in sterol metabolism, removing a methyl group from lanosterol in animals and fungi, or from obtusifoliol in plants. Azoles inhibit CYP51 function, leading to an accumulation of methylated sterol precursors. This perturbation of normal sterol metabolism compromises cell membrane integrity, resulting in growth inhibition or cell death. We have cloned and characterized a CYP51 from MAC that functions as a lanosterol 14alpha-demethylase. We show the direct interactions of azoles with purified MAC-CYP51 by absorbance and electron paramagnetic resonance spectroscopy, and determine the minimum inhibitory concentrations (MICs) of econazole, ketoconazole, itraconazole, fluconazole, and voriconazole against MAC. Furthermore, we demonstrate that econazole has a MIC of 4 mug/ml and a minimum bacteriocidal concentration of 4 mug/ml, whereas ketoconazole has a MIC of 8 mug/ml and a minimum bacteriocidal concentration of 16 mug/ml. Itraconazole, voriconazole, and fluconazole did not inhibit MAC growth to any significant extent.


Asunto(s)
Clonación Molecular , Sistema Enzimático del Citocromo P-450/metabolismo , Mycobacterium avium/enzimología , Oxidorreductasas/metabolismo , Antiinfecciosos/farmacología , Antifúngicos/química , Antifúngicos/farmacología , Azoles/química , Azoles/farmacología , Catálisis , Inhibidores Enzimáticos del Citocromo P-450 , Sistema Enzimático del Citocromo P-450/genética , Sistema Enzimático del Citocromo P-450/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Farmacorresistencia Microbiana , Espectroscopía de Resonancia por Spin del Electrón , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Macrólidos/farmacología , Espectrometría de Masas , Pruebas de Sensibilidad Microbiana , Oxidorreductasas/antagonistas & inhibidores , Oxidorreductasas/genética , Oxidorreductasas/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Esterol 14-Desmetilasa
10.
Proc Natl Acad Sci U S A ; 102(15): 5618-23, 2005 Apr 12.
Artículo en Inglés | MEDLINE | ID: mdl-15800038

RESUMEN

Cumulative mtDNA damage occurs in aging animals, and mtDNA mutations are reported to accelerate aging in mice. We determined whether aging results in increased DNA oxidative damage and reduced mtDNA abundance and mitochondrial function in skeletal muscle of human subjects. Studies performed in 146 healthy men and women aged 18-89 yr demonstrated that mtDNA and mRNA abundance and mitochondrial ATP production all declined with advancing age. Abundance of mtDNA was positively related to mitochondrial ATP production rate, which in turn, was closely associated with aerobic capacity and glucose tolerance. The content of several mitochondrial proteins was reduced in older muscles, whereas the level of the oxidative DNA lesion, 8-oxo-deoxyguanosine, was increased, supporting the oxidative damage theory of aging. These results demonstrate that age-related muscle mitochondrial dysfunction is related to reduced mtDNA and muscle functional changes that are common in the elderly.


Asunto(s)
Adenosina Trifosfato/biosíntesis , Envejecimiento/fisiología , Desoxiguanosina/análogos & derivados , Regulación de la Expresión Génica , Mitocondrias Musculares/genética , Mitocondrias Musculares/metabolismo , Músculo Esquelético/citología , Músculo Esquelético/fisiología , 8-Hidroxi-2'-Desoxicoguanosina , Adenosina Trifosfato/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Envejecimiento/genética , Citrato (si)-Sintasa/metabolismo , ADN Mitocondrial/genética , ADN Mitocondrial/metabolismo , Desoxiguanosina/análisis , Desoxiguanosina/metabolismo , Femenino , Prueba de Tolerancia a la Glucosa , Salud , Humanos , Masculino , Persona de Mediana Edad , Mitocondrias Musculares/enzimología , Proteínas Mitocondriales/análisis , Músculo Esquelético/enzimología , ARN/análisis , ARN/genética , ARN Mensajero/análisis , ARN Mensajero/genética , ARN Mitocondrial
11.
Am J Physiol Endocrinol Metab ; 286(6): E863-74, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15140753

RESUMEN

Proteomics is the comprehensive and systematic study of proteins, which are functional molecules. Although proteins are products of gene expression, there are more proteins than genes due to the posttranslational modifications of proteins, making the study of proteins difficult. Protein expression is tissue specific, and its function is modulated by variety of factors, including other proteins, phosphates, sulfates, carbohydrates, and lipids, as well as other metabolites. Because of the dynamic nature of protein expression and posttranslational modifications, identification and quantification of proteins alone are not sufficient to understand functional changes. Emerging technologies will allow investigators to perform a combination of metabolic labeling and identification as well as quantification and measurement of the synthesis rates of a large number of proteins in a tissue. This offers the opportunity to better understand the regulation of tissue functions. Rapid advances in mass spectrometry, protein purification techniques, isotope labeling of proteins, and bioinformatics are likely to improve our understanding of physiological states and altered functions in diseased states. Such mechanistic information will improve the ability to perform early diagnosis of tumors and other diseases and develop prognostic indexes and novel therapies.


Asunto(s)
Endocrinología/tendencias , Fisiología/tendencias , Proteómica/tendencias , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA